Ignite Creation Date:
2025-12-24 @ 4:03 PM
Ignite Modification Date:
2025-12-27 @ 5:04 AM
Study NCT ID:
NCT07216066
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-10-14
First Post:
2025-10-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11-24
Start Date Type:
ESTIMATED
Primary Completion Date:
2029-05-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-05-28
Completion Date Type:
ESTIMATED
First Submit Date:
2025-10-09
First Submit QC Date:
None
Study First Post Date:
2025-10-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-09
Last Update Post Date:
2025-10-14
Last Update Post Date Type:
ESTIMATED